ARCHIVES

Not All Women Benefitting From Less Invasive Staging

This article is from The Cancer Letter archive.

Vol. 31 No. 4 | April 25, 2008

Download PDF Visit The Full Archive

Related Articles

As Amgen, Johnson & Johnson Battle Over Anemia Market, Medicare Enters The Fray

December 13, 2002

Clinical Trials System “Slowly Unraveling,”

March 7, 2008

PV-10 Produces 51 Percent Response Rate in Phase II Trial

October 26, 2012

Univ. of Chicago Hospital Apologizes For Overdose Death

June 23, 1995

Alan Rabson Outlasts Them All, Even His Bosses, As DCBD Chief

January 15, 1982

Chemoprevention Clinical Trial RFA Being Developed For January Concept Review, Along With “Bridge” RFA

November 27, 1981